Kenya has been picked among nine countries for the trials of the new injectable HIV prevention drug that has been rolled out ...

Kenya has been selected as one of the 9 early adopter countries for the rollout of Lenacapavir (LEN), a long-acting ...

Lenacapavir, new twice-yearly HIV injection, raises hope for pill-weary patients. Discordant couples, sex workers hail ‘game ...

However, despite the Senate's decision to protect Pepfar from President Trump's proposed $400 million (Sh51.6 billion) ...

Renowned global health expert Rebecca Martin, PhD, recognized internationally for her leadership in developing and ...

These are the words of Rogers Omollo, founder and CEO of Activate Action – a youth-led non-profit organisation that supports ...

Integrating people-centered HIV care with primary health care is essential to improving access, equity and health outcomes, but doing so successfully requires coordinated policies, digital ...

The Joint United Nations Programme on HIV/AIDS (UNAIDS) warns that the global AIDS response is in crisis after a major ...

In collaboration with the Gates Foundation, Merck advances MK-8527 pre-exposure prophylaxis (PrEP) clinical trials globally ...

The U.S. Food and Drug Administration (FDA) has approved the first-ever long-acting injectable drug for HIV prevention. Until this week, the only FDA-licensed and approved medications for HIV pre ...

The WHO issued a global recommendation for lenacapavir, a highly effective, twice-yearly injection to prevent HIV infection. The recommendation follows a recent FDA approval for the drug, which ...

The Trump administration has lifted a freeze on federal funds for HIV prevention and surveillance programs, officials said, following an outcry from HIV prevention organizations, health experts ...